These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10074215)

  • 21. [Immunohistochemical hormonal mismatch and human epidermal growth factor type 2 [HER2] phenotype of brain metastases in breast cancer carcinoma compared to primary tumors].
    Joubert C; Boissonneau S; Fina F; Figarella-Branger D; Ouafik L; Fuentes S; Dufour H; Gonçalves A; Charaffe-Jauffret E; Metellus P
    Neurochirurgie; 2016 Jun; 62(3):151-6. PubMed ID: 27236733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Breast cancer classification is evolving].
    Penault-Llorca F
    Biol Aujourdhui; 2014; 208(4):251-9. PubMed ID: 25840451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical significance of tumor content of epidermal growth factor receptor in breast cancer].
    Mulero M; Fernández Raigoso P; Vázquez J; Lamelas ML; Corte D; Allende MT; Rodríguez JC; Vizoso F
    Rev Esp Med Nucl; 2003 Nov; 22(6):386-94. PubMed ID: 14588231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Luminal B breast tumors are not HER2 positive.
    Bhargava R; Dabbs DJ
    Breast Cancer Res; 2008; 10(5):404; author reply 405. PubMed ID: 18831725
    [No Abstract]   [Full Text] [Related]  

  • 25. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
    Kuo SH; Chen CL; Huang CS; Cheng AL
    Anticancer Res; 2000; 20(3B):2219-22. PubMed ID: 10928181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression.
    Santini D; Ceccarelli C; Taffurelli M; Pileri S; Marrano D
    J Pathol; 1996 Aug; 179(4):386-91. PubMed ID: 8869285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basal-like immunophenotype markers and prognosis in early breast cancer.
    Cassol L; Silveira Graudenz M; Zelmanowicz A; Cancela A; Werutsky G; Rovere RK; Garicochea B
    Tumori; 2010; 96(6):966-70. PubMed ID: 21388060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pS2 negativity in postmenopausal women with ER+PgR+ infiltrating ductal breast carcinoma is associated with reduced hormone dependence and increased proliferation and aneuploidy of the tumors.
    Ruibal A; Schneider J; del Rio C; Arias J; Núñez MJ; Piqueras V; Tejerina A
    Int J Biol Markers; 1999; 14(3):186-8. PubMed ID: 10569142
    [No Abstract]   [Full Text] [Related]  

  • 29. Flow cytometric steroid receptor analysis.
    Schutte B; Scheres HM; De Goeij AF; Rousch MJ; Blijham GH; Bosman FT; Ramaekers FC
    Prog Histochem Cytochem; 1992; 26(1-4):68-76. PubMed ID: 1484969
    [No Abstract]   [Full Text] [Related]  

  • 30. Invasive ductal carcinoma, fibroadenoma and adjacent breast stroma angiogenesis: an immunohistochemical and morphometrical study.
    Da Silva ID; De Lima GR; Gebrim LH; Baracat FF; Focchi GR; Evncio Neto J; Simões MJ
    Bull Assoc Anat (Nancy); 1996 Sep; 80(250):17-9. PubMed ID: 9127689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer.
    Iwase H; Itoh Y; Kuzushima T; Yamashita H; Iwata H; Toyama T; Hara Y; Kobayashi S
    Cancer Detect Prev; 1997; 21(1):29-35. PubMed ID: 9043760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New European approvals: Alpelisib for HRpos/HER2neg metastatic breast cancer with PIK3CA mutation].
    Corbaux P; Sabatier R
    Bull Cancer; 2020 Oct; 107(10):959-960. PubMed ID: 32977934
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of an immunoenzymatic assay for determining estrogen and progesterone receptors in breast tumors].
    Kopczyński Z; Stachowicz A; Kociałkowski K; Grodecka-Gazdecka S; Faryńska E
    Ginekol Pol; 1992; 63(10):528-33. PubMed ID: 1305562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer.
    Petit T; Wilt M; Velten M; Rodier JF; Fricker JP; Dufour P; Ghnassia JP
    Breast Cancer Res Treat; 2010 Nov; 124(2):387-91. PubMed ID: 20824324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The cytosolic hyaluronic acid level defines several clinico-biological properties of CD44v5-positive infiltrating ductal carcinoma of the breast].
    Ruibal A; Arias JI; Carmen del Río M; San Román JM; Lapeña G; Schneider J; Tejerina A
    Med Clin (Barc); 2000 Jul; 115(6):201-7. PubMed ID: 11002457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers.
    Nofech-Mozes S; Trudeau M; Kahn HK; Dent R; Rawlinson E; Sun P; Narod SA; Hanna WM
    Breast Cancer Res Treat; 2009 Nov; 118(1):131-7. PubMed ID: 19189211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Positive sentinel node risk in relation to oestrogen receptors in breast cancer in premenopausal and postmenopausal women].
    Bajén MT; Benítez AM; Domènech A; Ricart Y; Mora J; Notta P; Ramal D; Urruticoechea A; Soler T; Martín-Comin J
    Rev Esp Med Nucl; 2010; 29(6):289-92. PubMed ID: 20828880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.
    García Vicente AM; Soriano Castrejón A; Relea Calatayud F; Muñoz Madero V; Molina Garrido MJ; León Martín AA; Cordero García JM; Pilkington Woll JP; Chacón López-Muñiz I; Palomar Muñoz A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):308-14. PubMed ID: 23084013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative measurement of estrogen and progesterone receptors in breast lumps using image cytometry.
    Sarker SK; Mendiola R; Walker M; Coleman DV
    Anal Quant Cytol Histol; 1997 Feb; 19(1):87-91. PubMed ID: 9051191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.